Indications and uses
May temporarily relieve: • nervous exhaustion • fatigue • forgetfulness.** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Adrenapar
- Manufacturer
- Energique, Inc. | Apotheca Company
- Effective date
- 2024-07-29
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-01 02:27:40
Label at a glance#
ProductAdrenapar
Active ingredientAMERICAN GINSENG, AVENA SATIVA FLOWERING TOP, SUS SCROFA ADRENAL GLAND, SUS SCROFA HYPOTHALAMUS, ARSENIC TRIIODIDE, OYSTER SHELL CALCIUM CARBONATE, CRUDE, STRYCHNOS IGNATII SEED, LYCOPODIUM CLAVATUM SPORE, SODIUM CHLORIDE, STRYCHNOS NUX-VOMICA SEED, PHOSPHORIC ACID, PHOSPHORUS, ZINC
Label structure9 sections
Dosage and administration
• Adults and children 5 to 10 drops orally, 3 times daily or as otherwise directed by a health care professional. • Consult a physician for use in children under 12 years of age.
Contacts and useful links#
Label contents#
Full prescribing information#
ACTIVE INGREDIENTS:
(in each drop) Arsenicum Iodatum 12X 9.07%, Calcarea Carbonica 12X 9.07%, Glandula Suprarenalis Suis 8X 9.07%, Hypothalamus Suis 8X 9.07%, Ignatia Amara 12X 9.07%, Lycopodium Clavatum 12X 9.07%, Natrum Muriaticum 12X 9.07%, Nux Vomica 12X 9.07%, Phosphorus 12X 9.07%, Phosphoricum Acidum 12X 9.07%, Zincum Metallicum 12X 9.07%, Aralia Quinquefolia 3X 0.10%, Avena Sativa 3X 0.10%
PURPOSE:
Arsenicum Iodatum - swelling,** Calcarea Carbonica - fatigue,** Glandula Suprarenalis Suis - apathy,** Hypothalamus Suis - sadness,** Ignatia Amara – low appetite,** Lycopodium Clavatum - Faintness,** Natrum Muriaticum – heat intolerance,** Nux Vomica – early waking,** Phosphorus - thirst,** Phosphoricum Acidum - disinterest,** Zincum Metallicum - restlessness,** Aralia Quinquefolia - drowsiness,** Avena Sativa – sleeplessness**
**Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
USES:
May temporarily relieve: • nervous exhaustion • fatigue • forgetfulness.**
**Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
WARNINGS:
Stop use and ask a doctor if symptoms persist for more than 7 days.
If pregnant or breastfeeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
DO NOT USE IF TAMPER EVIDENT SEAL IS BROKEN OR MISSING
Store in a cool, dry place.
KEEP OUT OF REACH OF CHILDREN:
In case of overdose, get medical help or contact a Poison Control Center right away.
DIRECTIONS:
• Adults and children 5 to 10 drops orally, 3 times daily or as otherwise directed by a health care professional.
• Consult a physician for use in children under 12 years of age.
INACTIVE INGREDIENTS:
Demineralized water, 20% Ethanol.
QUESTIONS:
Dist. by Energique, Inc.
201 Apple Blvd
Woodbine, IA 51579
800.869.8078
PACKAGE LABEL DISPLAY:
ENERGIQUE
SINCE 1987
HOMEOPATHIC REMEDY
ADRENAPAR
1 fl. oz. (30 ml)
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 44911-0715-1 | Adrenapar | 30 mL in 1 BOTTLE, DROPPER | LIQUID | 30 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 44911-0715 | ADRENAPAR (ARALIA QUINQUEFOLIA, AVENA SATIVA, GLANDULA SUPRARENALIS SUIS, HYPOTHALAMUS SUIS, ARSENICUM IODATUM, CALCAREA CARBONICA, IGNATIA AMARA, LYCOPODIUM CLAVATUM, NATRUM MURIATICUM, NUX VOMICA, PHOSPHORICUM ACIDUM, PHOSPHORUS, ZINCUM METALLICUM) LIQUID [ENERGIQUE, INC.] | 1 | Current NDC, 1 package rows | 20240730_4080fcfb-7ef2-45f5-8c3b-592d3b66a120.zip |
Products#
Every source-derived product name is available through these pages.
- Adrenapar
- Aralia Quinquefolia, Avena Sativa, Glandula Suprarenalis Suis, Hypothalamus Suis, Arsenicum Iodatum, Calcarea Carbonica, Ignatia Amara, Lycopodium Clavatum, Natrum Muriaticum, Nux Vomica, Phosphoricum Acidum, Phosphorus, Zincum Metallicum
- AMERICAN GINSENG
- AVENA SATIVA FLOWERING TOP
- SUS SCROFA ADRENAL GLAND
- SUS SCROFA HYPOTHALAMUS
- ARSENIC TRIIODIDE
- ARSENIC CATION (3+)
- OYSTER SHELL CALCIUM CARBONATE, CRUDE
- STRYCHNOS IGNATII SEED
- LYCOPODIUM CLAVATUM SPORE
- SODIUM CHLORIDE
- CHLORIDE ION
- STRYCHNOS NUX-VOMICA SEED
- PHOSPHORIC ACID
- PHOSPHORUS
- ZINC
- WATER
- ALCOHOL
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 44911-0715 | 44911-0715-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| AMERICAN GINSENG | 8W75VCV53Q | ACTIB |
| AVENA SATIVA FLOWERING TOP | MA9CQJ3F7F | ACTIB |
| SUS SCROFA ADRENAL GLAND | 398IYQ16YV | ACTIB |
| SUS SCROFA HYPOTHALAMUS | N6R0856Z79 | ACTIB |
| ARSENIC TRIIODIDE | 3029988O2T | ACTIB |
| OYSTER SHELL CALCIUM CARBONATE, CRUDE | 2E32821G6I | ACTIB |
| STRYCHNOS IGNATII SEED | 1NM3M2487K | ACTIB |
| LYCOPODIUM CLAVATUM SPORE | C88X29Y479 | ACTIB |
| SODIUM CHLORIDE | 451W47IQ8X | ACTIB |
| STRYCHNOS NUX-VOMICA SEED | 269XH13919 | ACTIB |
| PHOSPHORIC ACID | E4GA8884NN | ACTIB |
| PHOSPHORUS | 27YLU75U4W | ACTIB |
| ZINC | J41CSQ7QDS | ACTIB |
| WATER | 059QF0KO0R | IACT |
| ALCOHOL | 3K9958V90M | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Adrenapar | ARALIA QUINQUEFOLIA, AVENA SATIVA, GLANDULA SUPRARENALIS SUIS, HYPOTHALAMUS SUIS, ARSENICUM IODATUM, CALCAREA CARBONICA, IGNATIA AMARA, LYCOPODIUM CLAVATUM, NATRUM MURIATICUM, NUX VOMICA, PHOSPHORICUM ACIDUM, PHOSPHORUS, ZINCUM METALLICUM | Energique, Inc. | 4080fcfb-7ef2-45f5-8c3b-592d3b66a120 | 2024-07-29 | Warnings | 44911-0715-1 44911-0715 44911071501 30377d99-e451-4d3b-bc82-5314468c7d64 4080fcfb-7ef2-45f5-8c3b-592d3b66a120 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.